Barry J. Simon
CIK: 0001647994
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ImmunityBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 5, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct25K shares at avg. $10.75$269K - Jun 24, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct25K shares at avg. $7.88$197K - Jun 4, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct23K shares at avg. $7.18$165K - Feb 24, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct75K shares at avg. $12.01$901K - Feb 23, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct165K shares at avg. $10.25$1.7M - Feb 22, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct15.2K shares- - Feb 22, 2026IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct6K shares at avg. $8.70$52K - Feb 20, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct10K shares at avg. $9.25$93K - Jan 20, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct75K shares at avg. $7.88$591K - Jan 20, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct77K shares at avg. $6.54$503K - Feb 22, 2025IBRX
ImmunityBio, Inc.
Exercise(M)Direct15.2K shares- - Feb 22, 2025IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct5.5K shares at avg. $3.42$19K - Jan 22, 2025IBRX
ImmunityBio, Inc.
Exercise(M)Direct110K shares at avg. $2.00$220K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 25,000 | $10.75 | $268,760 | Direct |
| Jun 24, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 25,000 | $7.88 | $196,908 | Direct |
| Jun 4, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 23,033 | $7.18 | $165,306 | Direct |
| Feb 24, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 75,000 | $12.01 | $900,788 | Direct |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 165,000 | $10.25 | $1,691,102 | Direct |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 15,243 | - | $0 | Direct |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 6,026 | $8.70 | $52,426 | Direct |
| Feb 20, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 10,000 | $9.25 | $92,500 | Direct |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 75,000 | $7.88 | $590,933 | Direct |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 76,967 | $6.54 | $503,364 | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Exercise(M) | 15,243 | - | - | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 5,453 | $3.42 | $18,649 | Direct |
| Jan 22, 2025 | IBRX ImmunityBio, Inc. | Exercise(M) | 110,020 | $2.00 | $219,864 | Direct |
1-13 of 13 transactions
About Simon Barry J.
Simon Barry J. (SEC CIK 0001647994) files insider reports with the SEC as Director of ImmunityBio, Inc. (IBRX).
Signal8 holds 8 ownership filings by Simon Barry J., all Form 4s, filed between Jan 24, 2025 and Oct 6, 2026. Those filings report 13 transactions, from Jan 22, 2025 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Simon Barry J.'s filings is in SAN DIEGO, CA.
Recent filings by Simon Barry J.
- Oct 5, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Jun 24, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Jun 4, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Feb 24, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Feb 23, 2026: Open-market sale of IBRX shares (Form 4, code S).
Other insiders filing for ImmunityBio, Inc. (IBRX)
- Cohen Cheryl, Director
- Selecky Christobel, Director
- BLASZYK MICHAEL D, Director
- Wendel Bruce, Director
- MAXWELL LINDA, Director
- Clark Wesley, Director